Extracellular matrix biology
- 1 December 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 21 (12) , 2211-2218
- https://doi.org/10.1097/00004872-200312000-00002
Abstract
The extracellular matrix (ECM) is a vital component of connective tissue, and collagen is a major constituent. There is growing evidence that changes in the composition of the cardiac and vascular matrix occurs during hypertension. Clinically, these effects are manifested as left ventricular hypertrophy and a reduction in arterial compliance and luminal diameter, which results in end organ ischaemia. The matrix metalloproteinases and their inhibitors have a central role in the regulation of the composition of the ECM. In this review, we discuss the mediators that affect the structure of the ECM in hypertension using results from animal and human studies.Keywords
This publication has 63 references indexed in Scilit:
- Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix MetalloproteinasesCirculation Research, 2002
- Tumor Necrosis Factor-α–Induced AT 1 Receptor Upregulation Enhances Angiotensin II–Mediated Cardiac Fibroblast Responses That Favor FibrosisCirculation Research, 2002
- Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP‐1 gene induction in human melanoma cell linesInternational Journal of Cancer, 2002
- Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory inductionCardiovascular Research, 2002
- IL-1β induces MMP-9 via reactive oxygen species and NF-κB in murine macrophage RAW 264.7 cellsBiochemical and Biophysical Research Communications, 2002
- Arterial Enlargement in Response to High Flow Requires Early Expression of Matrix Metalloproteinases to Degrade Extracellular MatrixExperimental and Molecular Pathology, 2002
- Activation of the Mitogen Activated Protein Kinase Extracellular Signal-Regulated Kinase 1 and 2 by the Nitric Oxide–cGMP–cGMP-Dependent Protein Kinase Axis Regulates the Expression of Matrix Metalloproteinase 13 in Vascular Endothelial CellsMolecular Pharmacology, 2002
- Differential Expression of Matrix Metalloproteinases After Stent Implantation and Balloon Angioplasty in the Hypercholesterolemic RabbitCirculation, 2001
- Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndromeAmerican Heart Journal, 2001
- Angiotensin II and extracellular matrix homeostasisThe International Journal of Biochemistry & Cell Biology, 1999